2023
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine
Grandi A, Tomasi M, Ullah I, Bertelli C, Vanzo T, Accordini S, Gagliardi A, Zanella I, Benedet M, Corbellari R, Di Lascio G, Tamburini S, Caproni E, Croia L, Ravà M, Fumagalli V, Di Lucia P, Marotta D, Sala E, Iannacone M, Kumar P, Mothes W, Uchil P, Cherepanov P, Bolognesi M, Pizzato M, Grandi G. Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine. Vaccines 2023, 11: 1546. PMID: 37896949, PMCID: PMC10610814, DOI: 10.3390/vaccines11101546.Peer-Reviewed Original ResearchSARS-CoV-2 vaccinesSARS-CoV-2Outer membrane vesiclesImmune responseSARS-CoV-2 elicitsSARS-CoV-2 variantsPotent immune responsesEffective immune responsePre-clinical efficacyDiverse SARS-CoV-2 variantsInherent adjuvanticityVaccinated miceIntranasal challengeVaccine dosesNeutralization titresEffective vaccineVirus infectionVaccination campaignHeterologous antigensVaccineVirus replicationSpike proteinInfectivity assaysTitresPotential need
2022
Comprehensive update on the monkeypox outbreak
Karim A, Kwon J, Karim M, Iftikhar H, Yasir M, Ullah I, Kang C. Comprehensive update on the monkeypox outbreak. Frontiers In Microbiology 2022, 13: 1037583. PMID: 36439787, PMCID: PMC9686369, DOI: 10.3389/fmicb.2022.1037583.Peer-Reviewed Original ResearchSARS-CoV-2Treatment of smallpoxSore throatMuscle achesSkin lesionsEndemic areasAntiviral drugsEndemic regionsPatterns of epidemicsSkin contactContact tracingMonkeypoxVaccineMonkeypox outbreakComprehensive updateOutbreakLack of informationTest capacityBody fluidsLymphadenopathyRashTecovirimatHeadacheFeverLesions